The team of prof. Joris Messens at the VIB-VUB Center for Structural Biology has provided new insights into the regulation of an important intracellular messenger molecule, hydrogen peroxide (H2O2), whose dysregulation has been linked to the development of several diseases, including cancer.
To fine-tune levels of H2O2, cells can sense changes in the concentration of H2O2 and respond by activating specific DNA regulation mechanisms. In bacteria, a protein called OxyR functions as such a H2O2-sensor. The exact mechanism of how OxyR senses H2O2 and changes its DNA binding properties, however, has hitherto remained unexplored.
By combining protein X-ray crystal structures with supporting molecular biological and biochemical experiments, Dr. David Young and Dr. Brandán Pedre together with international collaborators and co-workers of the Messens lab have provided new insight into this question. They have uncovered the precise H2O2 binding site and the conformational changes that OxyR uses to bind to DNA and stimulate the regulation of the cellular H2O2 concentration.
“Previously, the H2O2-induced structural change of OxyR has led to the development of fluorescence-based genetically encoded H2O2 sensors, offering a way to visualize compartment-specific endogenous H2O2 in real time in living cells in various pathological conditions”, explains Dr. David Young (VIB-VUB). Brandán Pedre (VIB-VUB) adds: “This new insight in the structural details of the OxyR protein not only clarifies how the cell arms itself against H2O2 changes but will also enable us to create more sensitive and specific OxyR-based fluorescent biosensors. Such sensors will help us to better understand how aberrant H2O2 signaling leads to disease and, in the long run, identify new drug targets”.
This work was made possible thanks to financial support from Vlaams Instituut voor Biotechnologie (VIB); Agency for Innovation by Science and Technology (IWT); equipment Grant HERC16 from the Hercules foundation; Research Foundation-Flanders G.0D79.14N; Research Foundation-Flanders Excellence of Science Project 30829584; the Erasmus Internship Program; the Strategic Research Programme SRP34 of the Vrije Universiteit Brussel; Russian Science Foundation grant 17-14-01086; Junta de Castilla y León; LE326U14 and University of León UXXI2016/00127.
Questions from patients
A breakthrough in research is not the same as a breakthrough in medicine. The realizations of VIB researchers can form the basis of new therapies, but the development path still takes years. This can raise a lot of questions. That is why we ask you to please refer questions in your report or article to the email address that VIB makes available for this purpose: firstname.lastname@example.org. Everyone can submit questions concerning this and other medically-oriented research directly to VIB via this address.